Results of treatment based on endocrine therapy for bone metastasis from breast cancer
Breast cancer patients with bone metastases at times survive for comparatively long periods, though complete cure is rare. The aim of the present study is to assess the value of endocrine therapy in the management of metastatic breast cancer patients. Of the 18 patients, the response rate (CR + PR) was 39% and the fifty percent-survival was 35 months. Improvement in symptoms and performance status was seen in 78% and 33% of the patients, respectively satisfactory palliation could be achieved with endocrine therapy for patients with metastatic breast cancer.
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
2001 |
|---|---|
| Erschienen: |
2001 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:28 |
|---|---|
| Enthalten in: |
Gan to kagaku ryoho. Cancer & chemotherapy - 28(2001), 13 vom: 22. Dez., Seite 2029-34 |
| Sprache: |
Japanisch |
|---|
| Beteiligte Personen: |
Sakurai, T [VerfasserIn] |
|---|
| Themen: |
33515-09-2 |
|---|
| Anmerkungen: |
Date Completed 22.01.2002 Date Revised 21.11.2013 published: Print Citation Status MEDLINE |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
NLM11680100X |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM11680100X | ||
| 003 | DE-627 | ||
| 005 | 20231222175119.0 | ||
| 007 | tu | ||
| 008 | 231222s2001 xx ||||| 00| ||jpn c | ||
| 028 | 5 | 2 | |a pubmed24n0390.xml |
| 035 | |a (DE-627)NLM11680100X | ||
| 035 | |a (NLM)11791380 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a jpn | ||
| 100 | 1 | |a Sakurai, T |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Results of treatment based on endocrine therapy for bone metastasis from breast cancer |
| 264 | 1 | |c 2001 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 500 | |a Date Completed 22.01.2002 | ||
| 500 | |a Date Revised 21.11.2013 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Breast cancer patients with bone metastases at times survive for comparatively long periods, though complete cure is rare. The aim of the present study is to assess the value of endocrine therapy in the management of metastatic breast cancer patients. Of the 18 patients, the response rate (CR + PR) was 39% and the fifty percent-survival was 35 months. Improvement in symptoms and performance status was seen in 78% and 33% of the patients, respectively satisfactory palliation could be achieved with endocrine therapy for patients with metastatic breast cancer | ||
| 650 | 4 | |a Case Reports | |
| 650 | 4 | |a English Abstract | |
| 650 | 4 | |a Journal Article | |
| 650 | 7 | |a Progesterone Congeners |2 NLM | |
| 650 | 7 | |a Gonadotropin-Releasing Hormone |2 NLM | |
| 650 | 7 | |a 33515-09-2 |2 NLM | |
| 650 | 7 | |a Epirubicin |2 NLM | |
| 650 | 7 | |a 3Z8479ZZ5X |2 NLM | |
| 650 | 7 | |a Cyclophosphamide |2 NLM | |
| 650 | 7 | |a 8N3DW7272P |2 NLM | |
| 650 | 7 | |a Medroxyprogesterone |2 NLM | |
| 650 | 7 | |a HSU1C9YRES |2 NLM | |
| 700 | 1 | |a Tatematsu, H |e verfasserin |4 aut | |
| 700 | 1 | |a Yamataka, K |e verfasserin |4 aut | |
| 700 | 1 | |a Yamamoto, T |e verfasserin |4 aut | |
| 700 | 1 | |a Kawahara, H |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Gan to kagaku ryoho. Cancer & chemotherapy |d 1993 |g 28(2001), 13 vom: 22. Dez., Seite 2029-34 |w (DE-627)NLM012601861 |x 0385-0684 |7 nnns |
| 773 | 1 | 8 | |g volume:28 |g year:2001 |g number:13 |g day:22 |g month:12 |g pages:2029-34 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 28 |j 2001 |e 13 |b 22 |c 12 |h 2029-34 | ||